PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.73 | 5.46
Analyze analyst forecasts for the company and compare them with competitors.
17.29B
The estimated revenue has increased from the previous period.
9.00B
The estimated EBITDA has increased from the previous period.
5.53
The estimated EPS has increased from the previous period.
5.08B
The estimated net income has increased from the previous period.
7.82B
The estimated EBIT has increased from the previous period.
1.75B
The estimated SG&A expenses have increased from the previous period.
Analyze DCF forecasts for the company and compare them with competitors.
18.31B
Revenue has decreased from the previous period.
3.20%
Revenue growth rate has decreased from the previous period.
9.53B
EBITDA has decreased from the previous period.
52.06%
EBITDA margin has decreased from the previous period.
8.28B
EBIT has decreased from the previous period.
45.23%
EBIT margin has decreased from the previous period.
1.25B
Depreciation has decreased from the previous period.
8.83B
Total cash has decreased from the previous period.
48.24%
Cash percentage has increased from the previous period.
1.82B
Receivables have decreased from the previous period.
9.94%
Receivables percentage has increased from the previous period.
3.28B
Inventories have decreased from the previous period.
17.89%
Inventory percentage has increased from the previous period.
750.49M
Accounts payable has decreased from the previous period.
4.10%
Payables percentage has increased from the previous period.
-3.35B
Capital expenditure has increased from the previous period.
-18.33%
CapEx percentage has increased from the previous period.
8.20%
WACC has decreased from the previous period.
8.57%
Cost of equity has decreased from the previous period.
4.06%
Cost of debt has decreased from the previous period.
0.95
Beta has decreased from the previous period.
919.00M
Diluted shares outstanding has increased from the previous period.
13.60B
Total debt has increased from the previous period.
171.92B
Total equity has decreased from the previous period.
185.51B
Total capital has decreased from the previous period.
7.33%
Debt weighting has increased from the previous period.
92.67%
Equity weighting has decreased from the previous period.
7.34B
EBIAT has decreased from the previous period.
5.10B
UFCF has decreased from the previous period.
4.00%
Long-term growth rate is unchanged from the previous period.
126.12B
Terminal value has decreased from the previous period.
105.55B
Enterprise value has decreased from the previous period.
10.40B
Net debt has increased from the previous period.
95.15B
Equity value has decreased from the previous period.
103.54
Equity value per share has decreased from the previous period.
View analysts' price targets and recommendations, and compare them with competitors.
$194.00
Analysts expect the stock price to decrease by 5.82%.
Buy
Positive consensus among analysts.